Medscape5d
Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life.
Secondary endpoints of efficacy (patient and physician global assessments and a quality of life assessment) also supported the use of ipratropium bromide nasal spray for rhinitis symptom control.
Drug Store News17d
Lupin receives FDA nod for generic Atrovent
Lupin has received approval from the Food and Drug Administration for ipratropium bromide nasal solution (nasal spray), 0.06%, which is a generic of Boehringer Ingelheim's Atrovent Nasal Spray, 0.06%.
Neurology Advisor3d
Zavegepant Nasal Spray Improves Pain, Function in Patients With Acute Migraine
Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.
Pharmabiz25d
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%
Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...